These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10160107)

  • 21. Economic and demographic consequences of AIDS in Namibia: rapid assessment of the costs.
    Ojo K; Delaney M
    Int J Health Plann Manage; 1997; 12(4):315-26. PubMed ID: 10177418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lifetime cost of treating a person with HIV.
    Hellinger FJ
    JAMA; 1993 Jul; 270(4):474-8. PubMed ID: 8320787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forecasting the medical care costs of the HIV epidemic: 1991-1994.
    Hellinger FJ
    Inquiry; 1991; 28(3):213-25. PubMed ID: 1833332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economic burden of HIV/AIDS on individuals and households in Nepal: a quantitative study.
    Poudel AN; Newlands D; Simkhada P
    BMC Health Serv Res; 2017 Jan; 17(1):76. PubMed ID: 28118830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct costs of health care for HIV/AIDS patients in Belgium.
    Decock RC; Depoorter AM; De Graeve D; Colebunders R
    AIDS Care; 2001 Dec; 13(6):721-31. PubMed ID: 11720642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district.
    Johnson AM; Adler MW; Crown JM
    Br Med J (Clin Res Ed); 1986 Aug; 293(6545):489-92. PubMed ID: 3091176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
    Krentz HB; Auld MC; Gill MJ;
    CMAJ; 2003 Jul; 169(2):106-10. PubMed ID: 12874156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspective.
    Lacey L; Youle M; Trueman P; Staszewski S; Schrappe M; Behrens M
    Pharmacoeconomics; 1999; 15 Suppl 1():39-53. PubMed ID: 10537441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994.
    Commun Dis Rep CDR Rev; 1996 Jan; 6(1):R1-21. PubMed ID: 8581117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital costs of treating haemophilic patients infected with HIV.
    Kennelly JM; Tolley KH; Ghani AC; Sabin CA; Maynard AK; Lee CA
    AIDS; 1995 Jul; 9(7):787-93. PubMed ID: 7546425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AIDS scenarios for The Netherlands; the economic impact on hospitals.
    Postma MJ; Jager JC; Dijkgraaf MG; Borleffs JC; Tolley K; Leidl RM
    Health Policy; 1995 Feb; 31(2):127-50. PubMed ID: 10141253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of HIV/AIDS on the national economy of India.
    Anand K; Pandav CS; Nath LM
    Health Policy; 1999 Jun; 47(3):195-205. PubMed ID: 10538918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome.
    Callaghan R; Prabu A; Allan RB; Clarke AE; Sutcliffe N; Pierre YS; Gordon C; Bowman SJ;
    Rheumatology (Oxford); 2007 Jan; 46(1):105-11. PubMed ID: 16728437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the cost of getting the price wrong?
    Beck EJ; Beecham J; Mandalia S; Griffith R; Walters MD; Boulton M; Miller DL
    J Public Health Med; 1999 Sep; 21(3):311-7. PubMed ID: 10528959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups.
    Longworth L; Young T; Buxton MJ; Ratcliffe J; Neuberger J; Burroughs A; Bryan S;
    Liver Transpl; 2003 Dec; 9(12):1295-307. PubMed ID: 14625830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient classification and cost analysis of AIDS and HIV: the case of Belgium.
    De Graeve D; Lescrauwaet B; Nonneman W
    Health Policy; 1997 Feb; 39(2):93-106. PubMed ID: 10165046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombia.
    Kuhlmann J; Keaei M; Conde R; Evers SMAA; Gonzalez J; Govers M; Hiligsmann M
    Value Health Reg Issues; 2017 Dec; 14():103-107. PubMed ID: 29254533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV infection and AIDS in England and Wales: general practitioners' workload and contact with patients.
    Gallagher M; Foy C; Rhodes T; Philips P; Setters J; Moore M; Naji S; Donaldson C; Bond J
    Br J Gen Pract; 1990 Apr; 40(333):154-7. PubMed ID: 2115352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare Costs for People with Serious Mental Illness in England: An Analysis of Costs Across Primary Care, Hospital Care, and Specialist Mental Healthcare.
    Ride J; Kasteridis P; Gutacker N; Aragon Aragon MJ; Jacobs R
    Appl Health Econ Health Policy; 2020 Apr; 18(2):177-188. PubMed ID: 31701484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mounting medical care cost for adult AIDS patients at the Faculty of Medicine, Siriraj Hospital: consideration for management.
    Suwanagool S; Ratanasuwan W; Techasathit W
    J Med Assoc Thai; 1997 Jul; 80(7):431-9. PubMed ID: 9277072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.